Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of CXCR4 Antagonists market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of CXCR4 Antagonistsmarket, defines the market attractiveness level of CXCR4 Antagonists market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of CXCR4 Antagonists industry, describes the types of CXCR4 Antagonists market, the applications of major players and the market size, and deeply analyzes the current situation of the global CXCR4 Antagonists market and the development prospects and opportunities of CXCR4 Antagonists industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global CXCR4 Antagonists market in Chapter 13.
By Player:
Merck
Biokine Therapeutics
Sanofi
Harmonic Pharma
Upsher-Smith Laboratories
Roche
GlycoMimetics
BioLineRx
Eli Lilly
X4 Pharmaceuticals
By Type:
BL-8040
GMI-1359
Plerixafor (AMD3100)
Balixafortide (POL6326)
USL311
Others
By End-User:
Cancer
HIV
Chronic Inflammatory Diseases
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 CXCR4 Antagonists Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 CXCR4 Antagonists Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 CXCR4 Antagonists Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 CXCR4 Antagonists Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise CXCR4 Antagonists Market Analysis and Outlook to 2022
-
7.1 Global CXCR4 Antagonists Consumption (2017-2022)
-
7.2 United States CXCR4 Antagonists Consumption (2017-2022)
-
7.3 Europe CXCR4 Antagonists Consumption (2017-2022)
-
7.4 China CXCR4 Antagonists Consumption (2017-2022)
-
7.5 Japan CXCR4 Antagonists Consumption (2017-2022)
-
7.6 India CXCR4 Antagonists Consumption (2017-2022)
-
7.7 South Korea CXCR4 Antagonists Consumption (2017-2022)
8 Region and Country-wise CXCR4 Antagonists Market Analysis and Outlook to 2028
-
8.1 Global CXCR4 Antagonists Consumption Forecast (2022-2028)
-
8.2 United States CXCR4 Antagonists Consumption Forecast (2022-2028)
-
8.3 Europe CXCR4 Antagonists Consumption Forecast (2022-2028)
-
8.4 China CXCR4 Antagonists Consumption Forecast (2022-2028)
-
8.5 Japan CXCR4 Antagonists Consumption Forecast (2022-2028)
-
8.6 India CXCR4 Antagonists Consumption Forecast (2022-2028)
-
8.7 South Korea CXCR4 Antagonists Consumption Forecast (2022-2028)
9 Global CXCR4 Antagonists Market Outlook by Types and Applications to 2022
-
9.1 Global CXCR4 Antagonists Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global BL-8040 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global GMI-1359 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Plerixafor (AMD3100) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Balixafortide (POL6326) Consumption and Growth Rate (2017-2022)
-
9.1.5 Global USL311 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global CXCR4 Antagonists Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global HIV Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Chronic Inflammatory Diseases Consumption and Growth Rate (2017-2022)
10 Global CXCR4 Antagonists Market Outlook by Types and Applications to 2028
-
10.1 Global CXCR4 Antagonists Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global BL-8040 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global GMI-1359 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Plerixafor (AMD3100) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Balixafortide (POL6326) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global USL311 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global CXCR4 Antagonists Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Chronic Inflammatory Diseases Consumption Forecast and Growth Rate (2022-2028)
11 Global CXCR4 Antagonists Import and Export Analysis (Top 5 Countries)
-
11.1 Global CXCR4 Antagonists Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global CXCR4 Antagonists Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 CXCR4 Antagonists Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global CXCR4 Antagonists Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck CXCR4 Antagonists Product and Service
-
14.2 Biokine Therapeutics
-
14.2.1 Biokine Therapeutics Company Details
-
14.2.2 Biokine Therapeutics CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Biokine Therapeutics CXCR4 Antagonists Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi CXCR4 Antagonists Product and Service
-
14.4 Harmonic Pharma
-
14.4.1 Harmonic Pharma Company Details
-
14.4.2 Harmonic Pharma CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Harmonic Pharma CXCR4 Antagonists Product and Service
-
14.5 Upsher-Smith Laboratories
-
14.5.1 Upsher-Smith Laboratories Company Details
-
14.5.2 Upsher-Smith Laboratories CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Upsher-Smith Laboratories CXCR4 Antagonists Product and Service
-
14.6 Roche
-
14.6.1 Roche Company Details
-
14.6.2 Roche CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Roche CXCR4 Antagonists Product and Service
-
14.7 GlycoMimetics
-
14.7.1 GlycoMimetics Company Details
-
14.7.2 GlycoMimetics CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlycoMimetics CXCR4 Antagonists Product and Service
-
14.8 BioLineRx
-
14.8.1 BioLineRx Company Details
-
14.8.2 BioLineRx CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 BioLineRx CXCR4 Antagonists Product and Service
-
14.9 Eli Lilly
-
14.9.1 Eli Lilly Company Details
-
14.9.2 Eli Lilly CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Eli Lilly CXCR4 Antagonists Product and Service
-
14.10 X4 Pharmaceuticals
-
14.10.1 X4 Pharmaceuticals Company Details
-
14.10.2 X4 Pharmaceuticals CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 X4 Pharmaceuticals CXCR4 Antagonists Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of CXCR4 Antagonists
-
Figure CXCR4 Antagonists Picture
-
Table Global CXCR4 Antagonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CXCR4 Antagonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CXCR4 Antagonists Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global CXCR4 Antagonists Consumption by Country (2017-2022)
-
Figure United States CXCR4 Antagonists Consumption and Growth Rate (2017-2022)
-
Table Europe CXCR4 Antagonists Consumption and Growth Rate (2017-2022)
-
Figure China CXCR4 Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Japan CXCR4 Antagonists Consumption and Growth Rate (2017-2022)
-
Figure India CXCR4 Antagonists Consumption and Growth Rate (2017-2022)
-
Figure South Korea CXCR4 Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global CXCR4 Antagonists Consumption Forecast by Country (2022-2028)
-
Figure United States CXCR4 Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe CXCR4 Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure China CXCR4 Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan CXCR4 Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure India CXCR4 Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea CXCR4 Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BL-8040 Consumption and Growth Rate (2017-2022)
-
Figure Global GMI-1359 Consumption and Growth Rate (2017-2022)
-
Figure Global Plerixafor (AMD3100) Consumption and Growth Rate (2017-2022)
-
Figure Global Balixafortide (POL6326) Consumption and Growth Rate (2017-2022)
-
Figure Global USL311 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Inflammatory Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global BL-8040 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GMI-1359 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Plerixafor (AMD3100) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Balixafortide (POL6326) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global USL311 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Inflammatory Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Table Global CXCR4 Antagonists Import by Region (Top 5 Countries) (2017-2028)
-
Table Global CXCR4 Antagonists Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck CXCR4 Antagonists Product and Service
-
Table Biokine Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Biokine Therapeutics CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biokine Therapeutics CXCR4 Antagonists Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi CXCR4 Antagonists Product and Service
-
Table Harmonic Pharma (Foundation Year, Company Profile and etc.)
-
Table Harmonic Pharma CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Harmonic Pharma CXCR4 Antagonists Product and Service
-
Table Upsher-Smith Laboratories (Foundation Year, Company Profile and etc.)
-
Table Upsher-Smith Laboratories CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Upsher-Smith Laboratories CXCR4 Antagonists Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche CXCR4 Antagonists Product and Service
-
Table GlycoMimetics (Foundation Year, Company Profile and etc.)
-
Table GlycoMimetics CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlycoMimetics CXCR4 Antagonists Product and Service
-
Table BioLineRx (Foundation Year, Company Profile and etc.)
-
Table BioLineRx CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioLineRx CXCR4 Antagonists Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly CXCR4 Antagonists Product and Service
-
Table X4 Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table X4 Pharmaceuticals CXCR4 Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table X4 Pharmaceuticals CXCR4 Antagonists Product and Service
-
